Upgrad to Agilent 7010 Mass Spectrometer

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Agilent Technologies, Inc. for an upgrade to the existing Agilent Mass Spectrometer. We require an identical system to our current Agilent 7010 GC-MS/MS system to keep up with our increased demands for the number of samples to analyze and to maintain consistent analysis across multi-year studies. The laboratory owns an Agilent 7000C GC-MS/MS system, which does not provide the necessary sensitivity for the analysis of terpenes in serum. A change of analytical platform will entail an overhaul of our established workflow, including the need for additional data processing software, multiple service contracts/engineer sources, and additional personnel training. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within ten (10) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.) Any quotation/response should be emailed to contract specialist at qaq5@cdc.gov by 12:00 pm on May 22, 2020.